Cargando…
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia
[(18)F]FDG-PET imaging has been recognized as a crucial diagnostic marker in Mild Cognitive Impairment (MCI), supporting the presence or the exclusion of Alzheimer's Disease (AD) pathology. A clinical heterogeneity, however, underlies MCI definition. In this study, we aimed to evaluate the pred...
Autores principales: | Cerami, Chiara, Della Rosa, Pasquale Anthony, Magnani, Giuseppe, Santangelo, Roberto, Marcone, Alessandra, Cappa, Stefano F., Perani, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300010/ https://www.ncbi.nlm.nih.gov/pubmed/25610780 http://dx.doi.org/10.1016/j.nicl.2014.12.004 |
Ejemplares similares
-
A biomarker study in long-lasting amnestic mild cognitive impairment
por: Cerami, Chiara, et al.
Publicado: (2018) -
The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
por: Dodich, Alessandra, et al.
Publicado: (2019) -
The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia
por: Cerami, Chiara, et al.
Publicado: (2016) -
Affective mentalizing and brain activity at rest in the behavioral variant of frontotemporal dementia
por: Caminiti, Silvia P., et al.
Publicado: (2015) -
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting
por: Perani, Daniela, et al.
Publicado: (2014)